Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma
暂无分享,去创建一个
P. Mclaughlin | A. Younes | L. Kwak | L. Fayad | S. Neelapu | M. Fanale | F. Hagemeister | B. Pro | F. Vega | M. Rodriguez | J. Romaguera | F. Samaniego | Tamer Khashab | L. Feng | Lei Feng | T. Khashab